Clinician reviewing a provider trust checklist with a patient in a bright medical office
| | |

The GLP-1 Trust Test: What an Online Provider Should Be Willing to Show You

Eight source-backed questions for checking an online GLP-1 provider’s clinical accountability, medication category, pharmacy, follow-up, claims, price, and commercial influence.

Six distinct peptide and metabolic health categories separated on a clinical workbench
| |

The Peptide Boundary Problem: Why GLP-1 Drugs and Research Peptides Are Not One Category

A source-backed guide to the six categories commonly blurred together in peptide marketing: FDA-approved drugs, compounded medication, investigational drugs, research-use products, longevity protocols, and supplements.

A clinician reviewing a telehealth consultation screen and transparency checklist beside an unbranded medication shipment box
| |

The GLP-1 Telehealth Transparency Scorecard: What a Platform Should Show Before You Trust It

A 20-point, source-backed framework for evaluating what a GLP-1 telehealth service discloses about medication identity, clinical accountability, pharmacy source, full cost, follow-up, claims, reviews, and commercial influence.